Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Sense Biodetection, a UK-based molecular diagnostics technology developer, has raised $15m in a series B extension that brought the round’s total to $65m. Koch Disruptive Technologies (KDT), the investment arm of industrial and chemicals group Koch Industries, led the extension having already led the initial $50m tranche in April 2021, when patient capital fund Cambridge…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
